Long non-coding RNA TRPM2-AS as a potential biomarker for hepatocellular carcinoma

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• Long non-coding RNAs (lncRNAs) play a role in hepatocellular carcinoma (HCC) development.
• The expression and clinical significance of TRPM2-AS in HCC are not well understood.

Purpose of the Study:

• To investigate the expression levels of TRPM2-AS in HCC tissues.
• To determine the association between TRPM2-AS expression and HCC patient prognosis and clinical features.

Main Methods:

• Quantitative reverse transcription PCR (qRT-PCR) was used to measure TRPM2-AS expression in 108 HCC patients.
• Correlation analyses were performed to link TRPM2-AS levels with clinicopathological factors and patient outcomes.
• The impact of TRPM2-AS on HCC cell proliferation and apoptosis was assessed using siRNA interference.

Main Results:

• TRPM2-AS expression was elevated in most HCC tissues.
• Higher TRPM2-AS levels correlated significantly with larger tumor size, advanced AJCC stage, poor tumor differentiation, and worse prognosis.
• siRNA-mediated knockdown of TRPM2-AS suppressed HCC cell proliferation and induced apoptosis in vitro.

Conclusions:

• Long non-coding RNA TRPM2-AS is upregulated in HCC and serves as a potential biomarker.
• TRPM2-AS inhibition demonstrates therapeutic potential by promoting apoptosis in HCC cells.